Trial intelligence / Profile preview

NAC in cannabis dependent adolescents

NCT01005810Phase 2Completed

Sponsor
Medical University of South Carolina
Start
Sep 2009
Primary completion
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of acetylcysteine in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Sep 2009; status: completed.

02

Drugs

acetylcysteine
03

Conditions

cannabis use disorder (CUD)

Beyond the preview

Go deeper on NCT01005810.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01005810.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call